← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Regents Of The University Of C
$399,788
Total funding
8
Grants
Funding over time
peak $399.8K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
DOE$399,788 · 3
NIH$0 · 5
By mechanism
—$399,788 · 3
N01$0 · 5
Investigators at Regents Of The University Of C
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
AWARD TO UNIVERSITY OF COLORADO, BOULDER AS A RESULT OF FOA DE-FOA-0000040, NUCLEAR ENERGY UNIVERSITY PROGRAMS - INFRASTRUCTURE SUPPORT PROGRAM.$370,000
· FY2009 · Department of Energy
BERYLLIUM REPOSITORY$29,788
· FY2009 · Department of Energy
FUNDAMENTAL STUDIES OF FRC TURBULENCE$0
· FY2009 · Department of Energy
DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002328$0
N01 · FY2004 · NS
IMMUNE TOLERANCE NETWORK-266015416$0
N01 · FY2004 · AI
PHASE II CHEMOPREVENTION CLINICAL TRIALS - AN EXPLORATORY STUDY TO EVA-261025139$0
N01 · FY2003 · CA
MEDICATIONS DEVELOPMENT FOR STIMULANT DEPENDENCE (MDS)-271038824$0
N01 · FY2003 · DA
DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002328$0
N01 · FY2003 · NS
IMMUNE TOLERANCE NETWORK-266015416$0
N01 · FY2002 · AI
IMMUNE TOLERANCE NETWORK-266015416$0
N01 · FY2005 · AI
DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002328$0
N01 · FY2005 · NS
PHASE II CHEMOPREVENTION CLINICAL TRIALS - AN EXPLORATORY STUDY TO EVA-261025139$0
N01 · FY2002 · CA
DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002328$0
N01 · FY2002 · NS
IMMUNE TOLERANCE NETWORK-266015416$0
N01 · FY2003 · AI
ROBOTICS FOR REHABILITATION THERAPY-27533352-275033352$0
N01 · FY2006 · HD
MEDICATIONS DEVELOPMENT FOR STIMULANT DEPENDENCE-271038824$0
N01 · FY2005 · DA
IMMUNE TOLERANCE NETWORK-266015416-266015416$0
N01 · FY2006 · AI
DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002328-265002328$0
N01 · FY2006 · NS
ROBOTICS FOR REHABILITATION THERAPY-27533352$0
N01 · FY2004 · HD